Media Coverage
BioAgilytix Makes Multi-Million-Dollar Investments in LC/MS Capabilities
Officials at BioAgilytix say the company has advanced its growth strategy with multi-million-dollar investments in liquid chromatography–mass spectrometry (LC/MS) capabilities, including new platforms and expanded…
The Battle to Make Drugs as Pure and Stable as Possible
Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them. Click for…
Company adds jobs with $20M facility despite canceled incentives
BioAgilytix continues to expand in the region despite having an incentives agreement canceled last year. Click for full article
BioAgilytix Expands Global CMC Analytical Services
BioAgilytix reports that it has expanded its global chemistry, manufacturing, and controls (CMC) analytical testing capabilities with the recently completed buildout of a 76,000-ft2 campus in…
Boosting Hamburg as a Science and Pharmaceutical Location Together With BioAgilytix
Andreas Rieckhof, State Councilor for Economic Affairs, LSN Managing Director Dr. Jürgen Walkenhorst and Juliane Worm, LSN Director Innovation & Technologies, visited the European headquarters…
Pre-existing Immunogenicity: How Will Cell and Gene Therapies Change Our Testing Approach?
In this article, Chief Scientific Officer at BioAgilytix, Jim McNally, Ph.D., explores why bioanalysts should prepare for the impending wave of C>s entering the development…
Bioanalytical Needs And Biosimilars: How Does The Molecule Compare?
Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions of this product to enter…
Trends Paving The Way For An Influx Of Biosimilar Development
Promising broader patient access to critical medicines, biosimilars offer a more cost-effective alternative therapeutic option compared with originator products. With many patents for blockbuster” commercial…
Overcoming Bioanalytical Hurdles In The Pharma And Life Sciences Sector
Summary Jim McNally’s article, ‘Overcoming bioanalytical hurdles in the pharma and life sciences sector,’ is now available in Manufacturing Chemist magazine: Click for full article
TBJ Reveals the 2020 Fast 50 Award Winners
BioAgilytix has recently been awarded the 2020 Fast 50 Award by Triangle Business Journal as one of the fastest-growing private companies within our region.